Cheng Zengjiang: innovation in the field of biomedicine to the best of times

& other; In the field of biomedicine, innovation is infinite space, and innovation to the best of time, let’s take innovation, improve people’s quality of life. Throughout the &; On November 29, BBS with freehand brushwork in traditional Chinese sponsors, BeiYuan biomedical technology (Beijing) co., LTD., chairman of Cheng Zengjiang in & other; Caijing conference 2018: forecast and strategy & throughout; So said.

1

with freehand brushwork in traditional Chinese BBS sponsors, BeiYuan biomedical technology (Beijing) co., LTD., chairman of Cheng Zengjiang

Cheng Zengjiang said that when a new drug research and development of adequate returns, it has the possibility of sustainable development. And on the drug research and development, we have too much space.

he also pointed out that consistency evaluation really is too important, because of generic drugs to solve the problem we use most of the foundation, it must do, but the reality is also facing great difficulties. When we raise the standard, is bound to guide enterprises to move in this direction, in a few years, we can really achieve the level of generics. , when you have reached the market.

here are his speech activity:

Cheng Zengjiang: I met a lot of sea turtles entrepreneurs, they come back to do the slogan of innovative medicine, medicine is to be the innovation of the Chinese people could afford, this is a personal feelings, is also a policy environment in China. If we do a hepatitis b treatment drug, is a curative drugs, a sell for 100 dollars, we should encourage or against? Should be encouraged. When a new drug research and development getting enough in return, it has the possibility of sustainable development. While on the drug research and development, we have too much space, unlike other industries, have no too much once met the innovation. But medicine field, we have too much can’t cure disease, there are too many disease can treatment but the effect is not good, is too large, or side effects or drug use is not very convenient. If do innovation in these areas, and the innovation can get return, should be encouraged.

a few years ago, because of the reason of policy, produced some baggage, has a backlog of generic drugs. Why overstock? Because there is no innovation atmosphere, also do not have innovation in return. Innovation consciousness has formed, are now looking for technical experts and the direction of the innovation. Before trial drug is more careful, not medicine. 2005 drug shortage of people is more of a chemical, 2005 people by 2010 is to analyze the shortage, after 2010, is the person who do preparation shortage, the future must be to do the shortage of clinical, because the registration measures for the administration of all points to the drugs do have clinical value. So, the direction has changed, especially this year October 8 LiangBan innovation ideas, solve the every aspect of our innovation. We are now the most is the shortage of talent, not capital, I met a lot of investors, feel no project can vote, did not have a good team. Over the years, coming back from abroad some scientists working, but now from the capital can support and policy space is not enough. This process is not can solve the moment. If settle payment end, in the future is not just a matter of a people’s livelihood, but an industry, maybe our innovation is something soon.

simple said the consistency, consistency evaluation really is too important, because of generic drugs to solve the problem we use most of the foundation, it must do, but the reality is also facing great difficulties. When we raise the standard, is bound to guide enterprises to move in this direction, in a few years, we can really achieve the level of generics. , when you have reached the market.

JinLiPing: good, because of the time, can not be invited to the scene audience participation. Technological progress eventually to serve the people, eventually to the treatment of the port, through the use of advanced medicine, medical apparatus and instruments development, I am very agree with this point, disruptive technology can profoundly changed the original is very difficult to overcome human get solid disease, it is worth waiting for. Because of time, do a summarize each guest.

Cheng Zengjiang: in the field of biomedicine, innovation is infinite space, and innovation to the best of time, let’s take innovation, improve people’s quality of life.

caijing conference 2018: forecast and strategy by caijing magazine, business network host, on November 28 to 30 days in Beijing.

(guest view according to the scene to speak, I confirm that I) without spokesman

Leave a Reply

Your email address will not be published. Required fields are marked *